The threat to software-backed businesses from artificial intelligence should prompt investors to shift focus from technology to companies that toil in the physical world, like miners, power producers and industrial firms, according to Ulrike Hoffmann-Burchardi, global head of equities and chief investment officer for the Americas at UBS Wealth Management. Image: Aedrian Salazar / Unsplash…
Introduction A seismic shockwave just hit the global legal technology sector. The announcement of a new AI assistant tailored for corporate legal teams has sent share prices of established European software giants into a tailspin, signaling a profound shift in how law will be practiced and priced in the algorithmic age. Image: Sora Shimazaki /…
Introduction A new front has opened in the battle for the future of software development. OpenAI, the research giant behind ChatGPT, has made a decisive power play by releasing a dedicated desktop application for its Codex AI, specifically for Apple computers. This isn’t just another software update; it’s a direct challenge to a burgeoning ecosystem…
Introduction In a high-stakes world where whispers of corporate discord can sway billion-dollar markets, Nvidia CEO Jensen Huang has forcefully batted away speculation of a fraying alliance with artificial intelligence pioneer OpenAI. Speaking to reporters in Taipei, Huang labeled reports of his discontent as “nonsense,” while simultaneously tempering expectations around the scale of a previously…
Introduction A landmark $1.2 billion financing deal, orchestrated by Deutsche Bank, has hit a startling roadblock. The culprit isn’t a traditional economic downturn or regulatory crackdown, but a profound and growing market anxiety: the fear that freely available artificial intelligence could render entire business models obsolete overnight. This high-stakes stalemate over the acquisition of AI-software…
Introduction A landmark $1.2 billion loan package, intended to finance a major acquisition in the red-hot AI software sector, has hit an unprecedented wall of investor skepticism. Led by Deutsche Bank, a syndicate of lenders now faces the stark prospect of being left holding the debt, a direct consequence of mounting fears that the very…
Introduction In a landmark decision poised to reshape prenatal diagnostics, the U.S. Food and Drug Administration has greenlit an artificial intelligence tool designed to peer into the earliest stages of human life. The software, developed by 2026 TechCrunch Disrupt Battlefield champion BioticsAI, assists clinicians in identifying potential fetal abnormalities from standard ultrasound images. This clearance…
Introduction A pioneering artificial intelligence tool, born from a startup competition stage, has now secured a coveted place in the clinical arena. BioticsAI, the company that captivated judges at TechCrunch Disrupt Battlefield 2026, announced this week it has received FDA 510(k) clearance for its software designed to analyze fetal ultrasound scans. This regulatory green light…
Introduction A seismic shift is underway in prenatal medicine. BioticsAI, the startup that captivated judges at TechCrunch Disrupt Battlefield just last year, has achieved a critical regulatory milestone. The U.S. Food and Drug Administration (FDA) has granted clearance for its pioneering artificial intelligence software, designed to assist clinicians in identifying potential fetal abnormalities from standard…
Introduction A Silicon Valley startup, once celebrated on the tech competition circuit, has now secured a far more consequential victory in the medical arena. BioticsAI, the 2026 winner of TechCrunch Disrupt’s prestigious Battlefield, announced Monday it has received U.S. Food and Drug Administration (FDA) clearance for its pioneering artificial intelligence software designed to analyze fetal…
